Recombinate

In the US, Recombinate (antihemophilic factor systemic) is a member of the drug class miscellaneous coagulation modifiers and is used to treat Hemophilia A.

US matches:

• Recombinate recombinant


• Recombinate

Ingredient matches for Recombinate

Coagulation Factor VIII , Human (rDNA)

Coagulation Factor VIII , Human (rDNA) is reported as an ingredient of Recombinate in the following countries:

• Slovenia

Coagulation Factor VIII , Human (rDNA) Octocog Alfa (a derivative of Coagulation Factor VIII , Human (rDNA)) is reported as an ingredient of Recombinate in the following countries:

• Argentina


• Australia


• Belgium


• Croatia (Hrvatska)


• Denmark


• Finland


• France


• Germany


• Greece


• Hong Kong


• Hungary


• Iceland


• Italy


• Latvia


• Lithuania


• Luxembourg


• New Zealand


• Slovakia


• Sweden


• Switzerland


• Taiwan


• United States

Coagulation Factor VIII , Human (rDNA) Rurioctocog Alfa (a derivative of Coagulation Factor VIII , Human (rDNA)) is reported as an ingredient of Recombinate in the following countries:

• Japan

International Drug Name Search